NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

Forget the reason why the hold in registration of new cases was imposed and then lifted without either explanation or obvious (to me) change in the protocols of the trial,
forget the reasons for the change in ownership of Cognate and the renaming of the UK branch to Advent (and all associated matters,)
consider the very upbeat Press Release of 1 September 2017
and please explain to me (in words of one or two syllables) what benefit the exceedingly uncommunicative Management can gain by delaying unblinding of the trial any longer?
Logically I just cannot see how all this presages the failure of the trial unless I'm missing something of fundamental importance involving criminal activities. Enlightenment would be appreciated.